These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7448740)

  • 1. Clinical application of estrogen receptor in breast cancer.
    Singhakowinta A; Saunders DE; Brooks SC; Samal B; Vaitkevicius VK
    Cancer; 1980 Dec; 46(12 Suppl):2932-8. PubMed ID: 7448740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells.
    Ogba N; Manning NG; Bliesner BS; Ambler SK; Haughian JM; Pinto MP; Jedlicka P; Joensuu K; Heikkilä P; Horwitz KB
    Breast Cancer Res; 2014 Dec; 16(6):489. PubMed ID: 25475897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of steroid hormone receptor content by chemotherapy and/or endocrine therapy in advanced breast cancer.
    Nomura Y; Tashiro H; Shinozuka K
    Cancer; 1985 Feb; 55(3):546-51. PubMed ID: 3965108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of estrophilin content of primary mammary cancer to eventual endocrine treatment.
    Block GE; Ellis RS; DeSombre E; Jensen E
    Ann Surg; 1978 Sep; 188(3):372-6. PubMed ID: 686899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptors and response to endocrine therapy and cytotoxic chemotherapy in advanced breast cancer.
    Rubens RD; Hayward JL
    Cancer; 1980 Dec; 46(12 Suppl):2922-4. PubMed ID: 7448737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid receptors and response to endocrine ablations in women with metastatic cancer of the breast.
    Dao TL; Nemoto T
    Cancer; 1980 Dec; 46(12 Suppl):2779-82. PubMed ID: 7448720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of estrogen receptor status as assessed by ligand-binding assay in patients with early-stage breast cancer treated with breast conserving surgery and radiation therapy.
    Takei H; Horiguchi J; Maemura M; Koibuchi Y; Oyama T; Yokoe T; Iino Y; Morishita Y
    Oncol Rep; 2002; 9(2):375-8. PubMed ID: 11836611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor: a prognostic factor in breast cancer.
    Samaan NA; Buzdar AU; Aldinger KA; Schultz PN; Yang KP; Romsdahl MM; Martin R
    Cancer; 1981 Feb; 47(3):554-60. PubMed ID: 7226005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor and endocrine responsiveness in Japanese versus American breast cancer patients.
    Nomura Y; Kobayashi S; Takatani O; Sugano H; Matsumoto K; McGuire WL
    Cancer Res; 1977 Jan; 37(1):106-10. PubMed ID: 830399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between steroid receptors and response to endocrine therapy and cytotoxic chemotherapy in metastatic breast cancer.
    Young PC; Ehrlich CE; Einhorn LH
    Cancer; 1980 Dec; 46(12 Suppl):2961-3. PubMed ID: 7448744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prediction of hormonal dependency of mammary cancer.
    Block GE; Jensen EV; Polley TZ
    Ann Surg; 1975 Sep; 182(3):342-52. PubMed ID: 169754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid hormone receptors and clinical usefulness in human breast cancer.
    Nomura Y; Yamagata J; Takenaka K; Tashiro H
    Cancer; 1980 Dec; 46(12 Suppl):2880-3. PubMed ID: 7448732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endocrine therapy of recurrent breast cancer].
    Nomura Y; Tashiro H
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):421-7. PubMed ID: 3890756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between primary breast tumor receptor status and patient survival.
    Blamey RW; Bishop HM; Blake JR; Doyle PJ; Elston CW; Haybittle JL; Nicholson RI; Griffiths K
    Cancer; 1980 Dec; 46(12 Suppl):2765-9. PubMed ID: 7448717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy.
    Kuukasjärvi T; Kononen J; Helin H; Holli K; Isola J
    J Clin Oncol; 1996 Sep; 14(9):2584-9. PubMed ID: 8823339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 expression status is a significant molecular marker in predicting the time to endocrine therapy failure in recurrent breast cancer: a cohort study.
    Kai K; Nishimura R; Arima N; Miyayama H; Iwase H
    Int J Clin Oncol; 2006 Dec; 11(6):426-33. PubMed ID: 17180510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of hormone receptor status between circulating tumor cells, primary tumor, and metastasis in breast cancer patients.
    Kalinsky K; Mayer JA; Xu X; Pham T; Wong KL; Villarin E; Pircher TJ; Brown M; Maurer MA; Bischoff FZ
    Clin Transl Oncol; 2015 Jul; 17(7):539-46. PubMed ID: 25613123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic oophorectomy in metastatic breast cancer.
    Conte CC; Nemoto T; Rosner D; Dao TL
    Cancer; 1989 Jul; 64(1):150-3. PubMed ID: 2731111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptors and breast cancer: prognostic and therapeutic implications.
    Gapinski PV; Donegan WL
    Surgery; 1980 Sep; 88(3):386-93. PubMed ID: 7414516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal surveillance for postoperative metastasis in breast cancer patients.
    Makita M; Sakai T; Ogiya A; Kitagawa D; Morizono H; Miyagi Y; Iijima K; Iwase T
    Breast Cancer; 2016 Mar; 23(2):286-94. PubMed ID: 25294313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.